PE20081494A1 - PIRROLO[1,2-a]IMIDAZOLDIONA EFICAZ EN EL TRATAMIENTO DE NEUROTOXICIDAD PERIFERICA INDUCIDAD POR AGENTES QUIMITERAPEUTICOS - Google Patents
PIRROLO[1,2-a]IMIDAZOLDIONA EFICAZ EN EL TRATAMIENTO DE NEUROTOXICIDAD PERIFERICA INDUCIDAD POR AGENTES QUIMITERAPEUTICOSInfo
- Publication number
- PE20081494A1 PE20081494A1 PE2007001562A PE2007001562A PE20081494A1 PE 20081494 A1 PE20081494 A1 PE 20081494A1 PE 2007001562 A PE2007001562 A PE 2007001562A PE 2007001562 A PE2007001562 A PE 2007001562A PE 20081494 A1 PE20081494 A1 PE 20081494A1
- Authority
- PE
- Peru
- Prior art keywords
- pirrolo
- imidazoldiona
- chimiterapeutic
- agents
- treatment
- Prior art date
Links
- 230000002093 peripheral effect Effects 0.000 title abstract 2
- 206010029350 Neurotoxicity Diseases 0.000 title 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title 1
- 206010044221 Toxic encephalopathy Diseases 0.000 title 1
- 230000007135 neurotoxicity Effects 0.000 title 1
- 231100000228 neurotoxicity Toxicity 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 4-METHYLPHENYL Chemical class 0.000 abstract 1
- 190000008236 CARBOPLATIN Chemical compound 0.000 abstract 1
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- 229940122803 Vinca alkaloid Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229960004562 carboplatin Drugs 0.000 abstract 1
- 230000000973 chemotherapeutic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000002902 organometallic compounds Chemical class 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN COMPUESTO DE FORMULA (I), O DENOMINADO 1-(4-METILFENIL)DIHIDRO-1H-PIRROLO[1,2-a]IMIDAZOL-2,5(3H,6H)-DIONA, PRESENTE EN UNA CANTIDAD DE 10 A 2500 MG; EN COMBINACION CON UNO O MAS AGENTES ANTICANCERIGENOS QUIMIOTERAPEUTICO SELECCIONADOS DE COMPUESTOS ORGANOMETALICOS, ALCALOIDES DE VINCA, TAXOL Y SUS DERIVADOS, SIENDO PREFERIDOS CISPLATINO, CARBOPLATINO, OXIPLATINO, COMPUESTOS DE RUTENIO, VINCRISTINA, VINBLASTINA, PACLITAXEL. ESTA COMPOSICION ES UTIL PARA EL TRATAMIENTO PREVENTIVO O TERAPEUTICO DE LA NEUROTOXICIDA PERIFERICA INDUCIDA POR QUIMIOTERAPEUTICOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06124142A EP1925304A1 (en) | 2006-11-15 | 2006-11-15 | Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20081494A1 true PE20081494A1 (es) | 2008-12-19 |
Family
ID=37882430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001562A PE20081494A1 (es) | 2006-11-15 | 2007-11-13 | PIRROLO[1,2-a]IMIDAZOLDIONA EFICAZ EN EL TRATAMIENTO DE NEUROTOXICIDAD PERIFERICA INDUCIDAD POR AGENTES QUIMITERAPEUTICOS |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7973066B2 (es) |
| EP (2) | EP1925304A1 (es) |
| JP (1) | JP2010509389A (es) |
| CN (1) | CN101605541A (es) |
| AR (1) | AR063819A1 (es) |
| AT (1) | ATE478668T1 (es) |
| AU (1) | AU2007321218A1 (es) |
| BR (1) | BRPI0718904A2 (es) |
| CA (1) | CA2669853A1 (es) |
| CL (1) | CL2007003281A1 (es) |
| DE (1) | DE602007008759D1 (es) |
| EA (1) | EA200900552A1 (es) |
| ES (1) | ES2347380T3 (es) |
| IL (1) | IL198689A0 (es) |
| MX (1) | MX2009005125A (es) |
| NZ (1) | NZ576995A (es) |
| PE (1) | PE20081494A1 (es) |
| WO (1) | WO2008058988A1 (es) |
| ZA (1) | ZA200904148B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20030573A1 (it) * | 2003-03-24 | 2004-09-25 | Nikem Research Srl | Composti ad azione nootropica, loro preparazione, |
| US9125898B2 (en) | 2008-11-14 | 2015-09-08 | Neurotune Ag | Acetam derivatives for pain relief |
| US20170224679A1 (en) * | 2014-07-31 | 2017-08-10 | Glaxosmithkline Intellectual Property Development Limited | Use of CXCR2 Antagonists For The Prevention and/or Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) |
| PL4025183T3 (pl) * | 2019-09-02 | 2025-09-22 | Syddansk Universitet | Induktory P-gp do stosowania w ochronie przed skutkami ubocznymi chemioterapii takimi jak neuropatia obwodowa wywołana chemioterapią (CIPN) oraz utrata włosów |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20030573A1 (it) * | 2003-03-24 | 2004-09-25 | Nikem Research Srl | Composti ad azione nootropica, loro preparazione, |
-
2006
- 2006-11-15 EP EP06124142A patent/EP1925304A1/en not_active Withdrawn
-
2007
- 2007-11-13 PE PE2007001562A patent/PE20081494A1/es not_active Application Discontinuation
- 2007-11-14 AR ARP070105067A patent/AR063819A1/es unknown
- 2007-11-14 JP JP2009536731A patent/JP2010509389A/ja active Pending
- 2007-11-14 ES ES07847162T patent/ES2347380T3/es active Active
- 2007-11-14 US US12/312,575 patent/US7973066B2/en not_active Expired - Fee Related
- 2007-11-14 AT AT07847162T patent/ATE478668T1/de not_active IP Right Cessation
- 2007-11-14 MX MX2009005125A patent/MX2009005125A/es active IP Right Grant
- 2007-11-14 EP EP07847162A patent/EP2094265B1/en active Active
- 2007-11-14 DE DE602007008759T patent/DE602007008759D1/de active Active
- 2007-11-14 AU AU2007321218A patent/AU2007321218A1/en not_active Abandoned
- 2007-11-14 CA CA002669853A patent/CA2669853A1/en not_active Abandoned
- 2007-11-14 BR BRPI0718904-4A patent/BRPI0718904A2/pt not_active IP Right Cessation
- 2007-11-14 CN CNA2007800424416A patent/CN101605541A/zh active Pending
- 2007-11-14 EA EA200900552A patent/EA200900552A1/ru unknown
- 2007-11-14 WO PCT/EP2007/062323 patent/WO2008058988A1/en not_active Ceased
- 2007-11-14 NZ NZ576995A patent/NZ576995A/en unknown
- 2007-11-15 CL CL200703281A patent/CL2007003281A1/es unknown
-
2009
- 2009-05-11 IL IL198689A patent/IL198689A0/en unknown
- 2009-06-12 ZA ZA200904148A patent/ZA200904148B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602007008759D1 (de) | 2010-10-07 |
| NZ576995A (en) | 2010-12-24 |
| US20100062077A1 (en) | 2010-03-11 |
| WO2008058988A1 (en) | 2008-05-22 |
| MX2009005125A (es) | 2009-11-02 |
| ATE478668T1 (de) | 2010-09-15 |
| ZA200904148B (en) | 2010-04-28 |
| EA200900552A1 (ru) | 2009-10-30 |
| BRPI0718904A2 (pt) | 2013-12-10 |
| IL198689A0 (en) | 2010-02-17 |
| EP1925304A1 (en) | 2008-05-28 |
| US7973066B2 (en) | 2011-07-05 |
| JP2010509389A (ja) | 2010-03-25 |
| CA2669853A1 (en) | 2008-05-22 |
| ES2347380T3 (es) | 2010-10-28 |
| CN101605541A (zh) | 2009-12-16 |
| AU2007321218A1 (en) | 2008-05-22 |
| EP2094265A1 (en) | 2009-09-02 |
| CL2007003281A1 (es) | 2008-06-27 |
| EP2094265B1 (en) | 2010-08-25 |
| AR063819A1 (es) | 2009-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR064736A1 (es) | Agonistas de gpcr | |
| HN2009000784A (es) | Dihidropirazolonas sustituidas | |
| ECSP099330A (es) | Compuesto de indol | |
| AR071055A1 (es) | Compuestos espiro, composiciones farmaceuticas y medicamentos que los comprenden, agente promotor de la secrecion de insulina y usos para la preparacion de medicamentos y composiciones farmaceuticas | |
| AR059957A1 (es) | DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER. | |
| ECSP11010760A (es) | Derivados de quinoxalindiona | |
| BRPI1013821A8 (pt) | piridinas substituídas como antagonistas de ccr3. | |
| NI201500148A (es) | USO DE 2, 3-DIHIDROIMIDAZO [1, 2-c] QUINAZOLINAS SUSTITUIDAS PARA TRATAR LINFOMAS | |
| NI200900184A (es) | Uso de compuestos inhibidores de quinaxolina de pi3k-alfa para el tratamiento del cáncer. | |
| CL2008003798A1 (es) | Compuestos derivados de heterobiciclos aromaticos sustituidos, inhibidores de pi3 quinasa; composicion farmaceutica; utiles en el tratamiento de cancer, melanomas, glioblastomas, entre otras enfermedades. | |
| AR067673A1 (es) | Derivados de 1,3 oxazinan - 2 - ona como inhibidores ciclicos de la 11 beta -hidroxiesteroide deshidrogenasa 1. composiciones farmaceuticas. | |
| CO6270257A2 (es) | Derivados de piridazinona | |
| SV2007002007A (es) | Compuestos de quinolina sustituidos ref. pc 25932a | |
| CL2010001415A1 (es) | Compuestos derivados de diazacarbazol, con actividad inhibidora de quinasa; composición farmacéutica que comprende a uno de los compuestos; y uso de la composición farmacéutica en la preparación de medicamentos para la inhibición del crecimiento celular o el tratamiento de un trastorno hiperproliferativo | |
| UA94606C2 (ru) | Производные тиоксантина, композиция, которая их содержит, и их применение в терапии | |
| DOP2010000022A (es) | Derivados de pirimidina 934 | |
| CL2008002049A1 (es) | Compuestos derivados de aminoindol macrociclicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
| CL2008001560A1 (es) | Compuestos derivados de heterociclo de nitrogenado, moduladores de gamma secretasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas como el alzheimer, sindrome de down; kit farmaceutico. | |
| AR059320A1 (es) | Composicion antitumorial que comprende un inhibidor de quinasas dependientes de ciclinas y un anticuerpo que inhibe un factor de crecimiento y/o un compuesto antimitotico | |
| AR066063A1 (es) | Derivados de triazol que son antagonistas de smo | |
| ECSP066958A (es) | Compuestos de morfolina | |
| PE20081494A1 (es) | PIRROLO[1,2-a]IMIDAZOLDIONA EFICAZ EN EL TRATAMIENTO DE NEUROTOXICIDAD PERIFERICA INDUCIDAD POR AGENTES QUIMITERAPEUTICOS | |
| AR049262A1 (es) | Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias | |
| BRPI0515991A (pt) | derivados de bisariluréia substituìda heterocìclica como inibidores de cinase | |
| AR061478A1 (es) | Compuesto triciclico y composicion farmaceutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |